<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Repligen Corporation

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Repligen Corporation

    Repligen Corporation is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Repligen’s corporate headquarters are in Waltham, MA (USA), with additional administrative and manufacturing operations in Marlborough, MA; Bridgewater, NJ; Rancho Dominguez, CA; Lund, Sweden; Breda, The Netherlands and Ravensburg, Germany. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Tony J. Hunt
    • FOUNDED
      1981
    • EMPLOYEES
      501-1000
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    MDisrupt LLC

    MDisrupt LLC

    MDisrupt is a Medical Diligence company for the healthtech industry, helping inves...

    MDisrupt is a Medical Diligence company for the...

    Filing Type:    PR
    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in ...

    CNS Pharmaceuticals is a pre-clinical stage bio...

    Amount Raised:    $628,558
    Fundraising Status:    EC
    Filing Type:    CF
    Eclipse Diagnostics Inc.

    Eclipse Diagnostics Inc.

    Eclipes Diagnostics develops CANABINOX, a handheld testing device that can accurat...

    Eclipes Diagnostics develops CANABINOX, a handh...

    Amount Raised:    $171,800.00
    Fundraising Status:    EC
    Filing Type:    CF
    LeMaitre Vascular, Inc.

    LeMaitre Vascular, Inc.

    LeMaitre Vascular is a leading global innovator, manufacturer and marketer of devi...

    LeMaitre Vascular is a leading global innovator...

    Filing Type:    PU
    Akers Biosciences Inc.

    Akers Biosciences Inc.

    Akers Biosciences, Inc. (aka Akers Bio) was founded in 1989, with the objective of...

    Akers Biosciences, Inc. (aka Akers Bio) was fou...

    Filing Type:    PU
    Intro-Blue, LLC

    Intro-Blue, LLC

    Intro-Blue combines an artificial intelligence (AI) platform with an independent p...

    Intro-Blue combines an artificial intelligence ...

    Fundraising Status:    EC
    Filing Type:    CF
    Verax Research Services, Inc.

    Verax Research Services, Inc.

    Knowledge Begets Confidence. Founded by proven and trusted Pharmaceutical and Medi...

    Knowledge Begets Confidence. Founded by proven ...

    Filing Type:    RA
    Forrester Research, Inc.

    Forrester Research, Inc.

    Forrester (Nasdaq: FORR) is one of the most influential research and advisory firm...

    Forrester (Nasdaq: FORR) is one of the most inf...

    Filing Type:    PU
    CryoPort, Inc.

    CryoPort, Inc.

    Cryoport is the industry’s most trusted provider of cold chain logistics solutio...

    Cryoport is the industry’s most trusted provi...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.